Comunicado de la FDA sobre la seguridad de los medicamentos: Nuevo factor de riesgo para la leucoencefalopatía multifocal progresiva. Abstract. PASQUALOTTO, Alessandro Comarú; MATTOS, Alice J.Z. de and ROCHA, Marineide Melo. Leucoencefalopatia multifocal progressiva confirmada por. A leucoencefalopatia multifocal progressiva (LMP) é uma doença desmielinizante do sistema nervoso central (SNC) causada pela reativação do vírus JC (JCV).

Author: Darisar Mogrel
Country: United Arab Emirates
Language: English (Spanish)
Genre: Business
Published (Last): 11 November 2006
Pages: 132
PDF File Size: 1.12 Mb
ePub File Size: 15.66 Mb
ISBN: 899-4-46843-800-5
Downloads: 67258
Price: Free* [*Free Regsitration Required]
Uploader: Kizahn

Read it at Google Books prrogressiva Find it at Amazon. Subcortical frontal and parieto-occipital regions are common locations. Unusual viral infections progressive multifocal leukoencephalopathy and cytomegalovirus disease after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. HIV encephalitis lesions are commonly periventricular, diffuse, symmetric, and tend to spare subcortical U-fibers.

In general, demyelination occurs in a multifocal and asymmetric manner.

Progressive multifocal leukoencephalopathy in non-HIV patient

Efalizumab, an antibody Anti-CD11a used in the treatment of psoriasis was also withdrawn from market multfiocal due to its association with PML Author information Article notes Copyright and License information Disclaimer. Stereotactic biopsy was performed and the anatomopathological examination revealed areas of intense demyelination with presence of large oligodendrocytes Immunohistochemistry staining on brain biopsy demonstrated JC virus DNA, characterizing progressive multifocal leukoencephalopathy PML.

Restoration of the adaptive immune response is crucial in controlling JCV replication and stabilizing disease. Gislaine Cristina Lopes Machado Porto. However, the widespread use of HIV antiretroviral drugs and new selective immunomodulatory and immunosuppressive medications, such as Rituximab and Natalizumab, had recently modified the epidemiology, clinical presentation and prognosis of PML 3.

Rarely, there is involvement of the spinal cord.

Progressive multifocal leukoencephalopathy in non-HIV patient

This lesion has minimal or no mass effect, no post-contrast enhancement and a thin rim of peripheral diffusion restriction reflecting the typical imaging findings seen in PML Cytarabine also known as ARA-Ca chemotherapy drug used to treat certain cancers, has been prescribed on an experimental basis for a small number leucencefalopatia non-AIDS PML patients, and stabilized the neurological condition of a minority of these patients. However, isolated posterior fossa involvement has also been reported Cognitive, language, motor and visual symptoms are commonly seen in this setting, with cognitive changes being more prominent, possibly because of the multifocal multiple sclerosis lesions already present in these patients 1.


Leucoencefalopqtia are no specific antivirals drugs against JCV.

Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. Evaluation of progressive multifocal leukoencephalopathy treatments in a Spanish cohort of HIV-infected patients: IRIS is defined as a paradoxical worsening of preexisting infectious processes or development of new symptoms following the initiation of highly active antiretroviral therapy HAART in HIV-infected individuals.

Progressive multifocal leukoencephalopathy a review of the neuroimaging features and differential diagnosis.

MuV Mumps Cytomegalovirus Cytomegalovirus esophagitis. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients a report of 57 cases from the Research on Adverse Drug Events and Reports project.

Cerebellar symptoms may appear in the case of lesion in the posterior fossa. It is progeessiva to another demyelinating disease, MS, but progresses much more quickly.

Progressive multifocal leukoencephalopathy | Radiology Reference Article |

BK virus MuV Mumps. Despite the support therapy, the patient evolved with clinical and radiological deterioration Figure 3.

N Engl J Med ; From Wikipedia, the free encyclopedia. T2-weighted MRI showing progressive multifocal leukoencephalopathy.

Leucoencefalopatia Multifocal Progressiva (PML)

Since restoration of the cellular immune response against JCV is the best predictor of survival in PML 8the introduction of combined antiretroviral drugs led to a significant improvement in mortality. Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patients. However, due to its biological properties, it remains active for as long as three months and during this period, PML can progress.


In patients on immunosuppression, this means stopping the drugs or using plasma exchange to accelerate the removal of the biologic agent that put the person at risk for PML. The prognosis for PML is reserved and there is no specific therapy. Thank you for updating your details. Some reports also state some benefit with cytarabine or mirtazapine, the latter especially in natalizumab-associated PML.

It is commonly multifocal and has an asymmetric pattern of demyelinationuni- or bilaterally, without mass effect, and invariably without contrast enhancement. Please help improve this section by adding citations to reliable leucoencefalopaatia. All articles with dead external links Articles with dead external leucoencefalppatia from April Articles with permanently dead external links CS1 maint: While the risk was estimated as 0.

Clinically, the development of PML in multiple sclerosis patients poses an additional difficulty in the diagnosis, since PML onset is frequently mistaken with MS exacerbation, stroke or other neurological condition National Institutes of Health.

The virus causes disease only when the immune system has been severely weakened. Support Radiopaedia and see fewer ads. Retrieved from ” https: We report the case of a year-old man with an indolent non-Hodgkin lymphoma stage IV diagnosed 15 months earlier.